Literature DB >> 32748268

Naples Prognostic Score as a novel prognostic prediction tool in video-assisted thoracoscopic surgery for early-stage lung cancer: a propensity score matching study.

Shuangjiang Li1,2, Hongyu Wang3,4, Zhang Yang2, Liang Zhao2, Wenyu Lv5, Heng Du6, Guowei Che7, Lunxu Liu1.   

Abstract

BACKGROUNDS: The Naples Prognostic Score (NPS) emerges as a novel prognostic scoring system in surgical oncology. We aim to assess the prognostic significance of preoperative NPS in patients undergoing completely video-assisted thoracoscopic surgery (VATS) lobectomy for early-stage non-small cell lung cancer (NSCLC) by propensity score matching (PSM) analysis.
METHODS: The present study was conducted on our single-center prospectively maintained database between January 2014 and December 2015. A Kaplan-Meier survival analysis using the log-rank test was used to distinguish differences in both overall survival (OS) and disease-free survival (DFS) between the patients stratified by preoperative NPS. Finally, multivariable Cox-proportional hazards regression analysis and PSM analysis were carried out to determine the independent prognostic factors for both OS and DFS.
RESULTS: There were 457 patients with operable primary stage I-II NSCLC included. Per 1-point increase in NPS was found to be significantly associated with unfavorable OS and DFS of NSCLC. Both OS and DFS were significantly shortened along with each number increase in the NPS group, showing a step-wise fashion. Such strong correlations between preoperative NPS and survival outcomes still remained validated after PSM analysis. In addition, NPS held the best discriminatory power for predicting both OS and DFS when compared to the other peripheral biomarkers. Multivariable analyses on the entire cohort and the PSM cohort demonstrated that preoperative NPS could be an independent prognostic indicator for both OS and DFS.
CONCLUSIONS: The NPS scoring system can serve as a novel risk stratification tool to refine prognostic prediction after VATS lobectomy for surgically resected NSCLC.

Entities:  

Keywords:  Naples prognostic score; Non-small cell lung cancer; Video-assisted thoracoscopic surgery

Year:  2020        PMID: 32748268     DOI: 10.1007/s00464-020-07851-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  2 in total

1.  Low Serum Levels of Pre-Surgical Total Cholesterol are Associated with Unfavorable Overall Survival in Patients with Operable Non-Small Cell Lung Cancer.

Authors:  Gu Zhang; Dan Zhang; Junzhou Wu; Fanrong Zhang; Ziyu Zhu; Kaiyan Chen; Nan Zhang; Jiaoyue Jin; Jianguo Feng; Nengming Lin; Yimin Zhang; Herbert Yu; Dan Su; Lisha Ying
Journal:  Clin Lab       Date:  2018-03-01       Impact factor: 1.138

2.  The Preoperative Prognostic Nutritional Index in Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study and Meta-Analysis.

Authors:  Xiaoxiao Fan; Guoqiao Chen; Yirun Li; Zhaoqi Shi; Lifeng He; Daizhan Zhou; Hui Lin
Journal:  J Invest Surg       Date:  2019-12-10       Impact factor: 2.533

  2 in total
  13 in total

1.  Naples Prognostic Score is an Independent Prognostic Factor in Patients with Small Cell Lung Cancer and Nomogram Predictive Model Established.

Authors:  Shuangqing Chen; Shicheng Liu; Siwei Xu; Shumin Cao; Zhaohui Han; Lingxin Kong; Dahu Ren; Guochen Duan
Journal:  J Inflamm Res       Date:  2022-06-28

2.  Effects of Radiotherapy on Survival of Esophageal Cancer Patients Receiving Immunotherapy: Propensity Score Analysis and Nomogram Construction.

Authors:  Yuanliu Nie; Guangyue Yao; Liang Li; Alei Feng; Wentao Zhang; Xiaoying Xu; Qiang Li; Zhe Yang
Journal:  Cancer Manag Res       Date:  2022-08-07       Impact factor: 3.602

3.  Clinical Significance of Preoperative Naples Prognostic Score in Patients With Non-Small Cell Lung Cancer.

Authors:  Dahu Ren; Wenbo Wu; Qingtao Zhao; Xiaopeng Zhang; Guochen Duan
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

4.  Prognostic laboratory score to predict 14-day mortality in terminally ill patients with respiratory malignancy.

Authors:  Mari Tanaka; Natsuko Kawai; Norihiro Yuasa
Journal:  Int J Clin Oncol       Date:  2022-01-23       Impact factor: 3.402

5.  Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction.

Authors:  Jianping Xiong; Yaqin Wang; Wenzhe Kang; Fuhai Ma; Hao Liu; Shuai Ma; Yang Li; Peng Jin; Haitao Hu; Yantao Tian
Journal:  Front Oncol       Date:  2020-12-16       Impact factor: 6.244

6.  Albumin-To-Alkaline Phosphatase Ratio as a Novel and Promising Prognostic Biomarker in Patients Undergoing Esophagectomy for Carcinoma: A Propensity Score Matching Study.

Authors:  Xianying Zhu; Dongni Chen; Shuangjiang Li; Wenbiao Zhang; Yongjiang Li; Xiaoyu Wang; Jian Zhou; Zhesheng Wen
Journal:  Front Oncol       Date:  2021-10-20       Impact factor: 6.244

7.  Naples prognostic score, a novel prognostic score for patients with high- and intermediate-risk gastrointestinal stromal tumours after surgical resection.

Authors:  Hao Wu; Mengdi Fu; Xiaozhou Xie; Jianqiao Yang; Yang Liu; Fengying Du; Zhen Fang; Liang Shang; Leping Li
Journal:  World J Surg Oncol       Date:  2022-03-01       Impact factor: 2.754

8.  Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer.

Authors:  Dong Guo; Jiafeng Liu; Yanping Li; Chao Li; Quan Liu; Shengjun Ji; Shuchai Zhu
Journal:  J Inflamm Res       Date:  2021-11-23

9.  Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma.

Authors:  Ji-Feng Feng; Jian-Ming Zhao; Sheng Chen; Qi-Xun Chen
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

10.  Gamma-Glutamyl Transpeptidase to Platelet Ratio Is a Novel and Independent Prognostic Marker for Resectable Lung Cancer: A Propensity Score Matching Study.

Authors:  Liang Zhao; Shuangjiang Li; Juan Ju; Haining Zhou; Hongyu Wang; Guowei Che
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-02-03       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.